tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Income Statement

Compare
488 Followers

Spyre Therapeutics Income Statement

Last quarter (Q3 2025), Spyre Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Spyre Therapeutics's net income was $-11.18M. See Spyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 886.00K$ 2.33M$ 18.74M$ 0.00
Gross Profit
$ 0.00$ 886.00K$ 2.33M$ 18.74M$ -1.62M
Operating Expenses
$ 208.57M$ 243.19M$ 87.11M$ 84.39M$ 79.86M
Depreciation and Amortization
$ 0.00$ 964.00K$ 1.96M$ 1.58M$ 1.62M
EBITDA
$ -207.97M$ -127.60M$ -82.82M$ -64.07M$ -79.27M
Operating Income
$ -208.57M$ -242.30M$ -84.78M$ -65.65M$ -81.48M
Other Income/Expenses
$ 599.00K$ -96.51M$ 830.00K$ -11.00K$ 588.00K
Pretax Income
$ -207.97M$ -338.82M$ -83.95M$ -65.66M$ -80.89M
Net Income
$ -208.02M$ -338.79M$ -83.81M$ -65.80M$ -80.89M
Per Share Metrics
Basic EPS
$ -3.18$ -46.15$ -24.86$ -25.02$ -37.89
Diluted EPS
$ -3.18$ -46.15$ -24.86$ -25.02$ -37.89
Weighted Average Shares Outstanding
47.03M 6.90M 3.37M 2.63M 2.13M
Weighted Average Shares Outstanding (Diluted)
47.03M 6.90M 3.37M 2.63M 2.13M
Currency in USD

Spyre Therapeutics Earnings and Revenue History